4//SEC Filing
OCLASSEN GLENN A 4
Accession 0001209191-18-038596
CIK 0001660334other
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 4:48 PM ET
Size
7.5 KB
Accession
0001209191-18-038596
Insider Transaction Report
Form 4
OCLASSEN GLENN A
Director
Transactions
- Conversion
Common Stock
2018-06-19+200,734→ 290,421 total(indirect: See Footnote) - Conversion
Series A Convertible Preferred Stock
2018-06-19−200,734→ 0 total(indirect: See Footnote)→ Common Stock (200,734 underlying)
Footnotes (2)
- [F1]Each share of Series A Convertible Preferred Stock was convertible at any time at the option of the holder into Common Stock, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.
- [F2]The shares are held directly by The Glenn A. Oclassen 2016 Trust dated November 30, 2016 (the "Trust"). The Reporting Person serves as trustee of the Trust.
Documents
Issuer
Verrica Pharmaceuticals Inc.
CIK 0001660334
Entity typeother
Related Parties
1- filerCIK 0001210529
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 4:48 PM ET
- Size
- 7.5 KB